Wuhan Wansheng Biotechnology (revision 16)
Old revision·02:51, 31 Aug 2024·ForgeryFinder
| Wuhan Wansheng Biotechnology Co., Ltd. | |
|---|---|
| Legal name | Wuhan Wansheng Biotechnology Co., Ltd. |
| Trading name | WWB |
| Other designations | Wansheng Bio, WWBT |
| Identity | |
| Founded | Not documented |
| Headquarters | Wuhan, Hubei, China |
| Industry | Research-compound supply |
| Shop domain | Visit WWB |
| Organisation infobox · conventions | |
Wuhan Wansheng Biotechnology Co., Ltd. (trading as WWB; wuhanwanshengbio.com) is a research-compound supplier based in Wuhan, Hubei, China, supplying research peptides, SARMs and raw materials, and notable for having one of the largest published third-party test-report sets of any organisation covered on this wiki.[1][2]
The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]The organisation operates from Wuhan, Hubei. Neither an incorporation year nor a primary trading domain is documented in sources available to this wiki, and the article does not supply either: an unverified founding year is worse than a blank, because a reader cannot tell one from a verified one.[1]
What distinguishes the organisation is the size of its published testing record. A body of several hundred third-party reports has been associated with its material, which is a substantially larger set than for any other entity covered here.[5] That volume is the strongest element of its notability case, and it is also the subject of the longest-running dispute on this talk page — because a large number of reports is not the same as a good testing record, and the article has to be careful not to let the first imply the second.
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
References
- ^ a b National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.